The role of vascular endothelial growth factor a polymorphisms in breast cancer (Q26851522)

Pornchai O-charoenrat

series ordinal

2

1 reference

International Journal of Molecular Sciences

language of work or name

1 reference

13 November 2012

8 references

13 March 2019

3 April 2019

19 June 2019

17 June 2019

30 June 2019

14 September 2019

20 November 2019

8 references

13 March 2019

3 April 2019

19 June 2019

17 June 2019

30 June 2019

14 September 2019

20 November 2019

13

1 reference

issue

11

1 reference

page(s)

14845-64

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

7 references

13 March 2019

3 April 2019

19 June 2019

17 June 2019

30 June 2019

14 September 2019

on focus list of Wikimedia project

20 November 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Hallmarks of Cancer: The Next Generation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

7 April 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular endothelial growth factor is a secreted angiogenic mitogen

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Tumorigenesis and the angiogenic switch

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular endothelial growth factor (VEGF) and its receptors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

The biology of vascular endothelial growth factor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Angiogenesis-associated sequence variants relative to breast cancer recurrence and survival.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Dissecting tumour pathophysiology using intravital microscopy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

VEGF receptor signal transduction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular remodelling during the normal and malignant life cycle of the mammary gland

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Prognostic value of vascular endothelial growth factor in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Determinants of tumor blood flow: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary Hyperplasia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer.

31 May 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Polymorphisms in the 5′- and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS131114845

New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509613

VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls

28 November 2018

1 reference

12 December 2020

Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis

1 reference

12 December 2020

The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women

1 reference

12 December 2020

Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies

1 reference

12 December 2020

Angiogenesis and risk of breast cancer in women with fibrocystic disease

1 reference

12 December 2020

Effects of vascular endothelial growth factor on hemodynamics and cardiac performance

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

12 December 2020

Tumor induction of VEGF promoter activity in stromal cells

1 reference

12 December 2020

VEGF is required for growth and survival in neonatal mice

1 reference

12 December 2020

Serum VEGF levels in women with a benign breast tumor or breast cancer

1 reference

12 December 2020

VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer

1 reference

12 December 2020

Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals

1 reference

12 December 2020

First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study

1 reference

12 December 2020

Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production

1 reference

12 December 2020

Association of genetic polymorphisms in the VEGF gene with breast cancer survival

1 reference

12 December 2020

Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors

1 reference

12 December 2020

Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection

1 reference

12 December 2020

Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer

1 reference

12 December 2020

An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma

1 reference

12 December 2020

A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes

1 reference

12 December 2020

Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma

1 reference

12 December 2020

Cytokine gene polymorphisms and breast cancer susceptibility and prognosis

1 reference

12 December 2020

A multigenic approach to predict breast cancer risk

1 reference

12 December 2020

Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients

1 reference

12 December 2020

Association of polymorphisms of angiogenesis genes with breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS131114845

0 references

1 reference

PubMed publication ID

23203097

1 reference